ASX/200 Closed Higher by 0.96%, Lifted by Healthcare

May 31, 2024

By the end of the trading session on 31 May 2024, the benchmark index S&P/ASX 200 ended higher by 0.96% and settled at 7,701.70.  Out of 11 sectors, 10 sectors closed higher along with the ASX 200.

Healthcare and Consumer Staples were the top-gaining sector, gaining 1.86% and 1.25% respectively in their index values. A-REIT was the top-lossing sector, lossing 0.06% respectively in their index values. 

Telix Pharmaceauticals Limited (ASX: TLX) and West African Resources Limited (ASX: WAF) are the top-gaining stocks, gaining 15.311% and 6.993% in their stock prices. On the other hand, Megaport Limited (ASX: MP1) and The Star Entertainment Limited (ASX: SGR) are the top-losing stocks and are declining by 3.419% and 2.174% in their stock prices.

Copyright © 2022 Kapitales Research

Top gainer for the day:

  • Healthcare (Down 1.86%)
  • Consumer Staples (Down 1.25%)

Top loser for the day:

  • A-REIT (Down 0.06%)

Other Factors influencing the market:

  • Treasury Wine Estates rose 2.8% to $11.33, Bega Cheese surged 6.2% to $4.46, and Woolworths increased 2% to $31.60.
  • Telix Pharmaceuticals jumped 15.3% to $18.15 following a positive note from broker Wilsons and favorable clinical trial results.
  • Guzman y Gomez announced plans to list on the ASX in June, targeting an enterprise valuation of 32.5 times its forecasted 2025 EBITDA of $59.9 million.
  • Bond traders are adjusting interest rate expectations after Australian inflation rose to 3.6% year-on-year in April.
  • The Dow closed down 0.86%, the S&P 500 fell 0.60%, and the NASDAQ dropped 1.08%.
  • The Hang Seng index decreased by 0.02%, while the FTSE 100 increased by 0.59%.

Top 5 Gainers and Losers Scoreboard:

90-Day Average Volume Outlier:

 

 

 

 

 

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com